|
Arixtra Gets EC Go-Ahead
Sanofi-Synthelabo and Organon announced that fondaparinux sodium (Arixtra) has
received marketing approval from the European Commission for "prevention of
venous thromboembolic events (VTE) in patients undergoing major orthopedic
surgery of the lower limbs such as hip fracture, major knee or hip fracture,
major knee or hip replacement surgery."
More
on this Story
BFAD Okays Montelukast for Kids
The Bureau of Food and Drugs (BFAD) recently approved a new dosage of
montelukast sodium for the prevention and chronic treatment of asthma in
children ages two to five.
More
on this Story
Multi-light IPL System at USTH
The University of Santo Tomas Hospital offers the latest in the treatment of a
variety of skin disorders through the use of the Multilight Intense Pulse Light
(IPL) System. This single device with both epilight and IPL heads provides
permanent solutions to a number of skin and hair problems.
More
on this Story
St. Luke's Introduces Patch Testing for Contact Dermatitis
The St.
Luke's Dermatology Center (DERMCEN) offers patch testing at its Contact
Dermatitis and Patch Testing Unit.
More
on this Story
Using Health for Tourism
In some
countries in Asia, health tourism became popular because of the increasing
demand of travelers for their health check and medical treatment, not to mention
the need for an interesting and enjoyable trip. These include services involving
physical exercise, therapy, and diet control.
More
on this Story
|
